Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_assertion description "[ The APOA5 19W variant is associated with increased plasma triglycerides. However, there is no evidence that APOA5 S19W, -12,238T > C, APOA4 T347S and APCC3 -482C > T SNPs are major risk factors of CHD in French men.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_assertion evidence source_evidence_literature NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_assertion SIO_000772 16321685 NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_assertion wasDerivedFrom gad-20150221 NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_assertion wasGeneratedBy ECO_0000203 NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.
- gad-20150221 importedOn "2015-02-21" NP59032.RAeG9UzzV5b1pEN72dA-i5Oo-RNVui_H8G5DHZc2BsNhI130_provenance.